Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Arch Virol
2023 Jan 07;1682:47. doi: 10.1007/s00705-022-05632-2.
Show Gene links
Show Anatomy links
MEK/ERK activation plays a decisive role in Zika virus morphogenesis and release.
Valencia HJ
,
Mendonça DC
,
Marinho PES
,
Henriques LR
,
Drumond BP
,
Bonjardim CA
.
???displayArticle.abstract???
Brazil has experienced an increase in outbreaks caused by flaviviruses. The high incidence of dengue fever, the morbidity of Zika in children, and the high mortality of yellow fever have affected millions in recent years. Deciphering host-virus interactions is important for treating viral infections, and the mitogen-activated protein kinases (MAPK) are an interesting target because of their role in flavivirus replication. In particular, mitogen-activated protein kinase kinase (MEK), which targets extracellular-signal-regulated kinase (ERK), is necessary for dengue and yellow fever infections. In this study, we evaluated the role of the MEK/ERK pathway and the effect of the MEK inhibitor trametinib on the Asian ZIKV strain PE243 and the prototype African ZIKV strain MR766, addressing genome replication, morphogenesis, and viral release. ZIKV infection stimulated ERK phosphorylation in Vero cells at 12 and 18 hours postinfection (hpi). Trametinib showed sustained antiviral activity, inhibiting both ZIKV strains for at least four days, and electron microscopy showed probable inhibition of ZIKV morphogenesis. ZIKV PE243 can complete one cycle in Vero cells in 14 hours; genome replication was detected around 8 hpi, intracellular viral particles at 12 hpi, and extracellular progeny at 14 hpi. Treatments at 6-hour intervals showed that trametinib inhibited late stages of viral replication, and the titration of intra- or extracellular virions showed that the treatment especially affected viral morphogenesis and release. Thus, ZIKV stimulated ERK phosphorylation during viral morphogenesis and release, which correlated with trametinib inhibiting both the signaling pathway and viral replication.
CBB-APQ-01670-11 Fundação de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG), CBB-AUC-00071-15 Fundação de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG), CBB-APQ-04178-17 FAPEMIG/PPSUS (Pesquisa Para o Serviço Único de Saúde), CBB-APQ-03360-17 FAPEMIG/PPSUS (Pesquisa Para o Serviço Único de Saúde), 88882.348380/2010 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Albarnaz,
MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
2014, Pubmed
Albarnaz,
MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
2014,
Pubmed
Bonjardim,
Viral exploitation of the MEK/ERK pathway - A tale of vaccinia virus and other viruses.
2017,
Pubmed
Carvajal,
Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).
2015,
Pubmed
Davy,
G2/M cell cycle arrest in the life cycle of viruses.
2007,
Pubmed
Dochi,
Trametinib suppresses HIV-1 replication by interfering with the disassembly of human immunodeficiency virus type 1 capsid core.
2018,
Pubmed
Donald,
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.
2016,
Pubmed
Flaherty,
Improved survival with MEK inhibition in BRAF-mutated melanoma.
2012,
Pubmed
Frumence,
The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-β production and apoptosis induction.
2016,
Pubmed
Gilmartin,
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition.
2011,
Pubmed
Lanciotti,
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.
2008,
Pubmed
Lavoie,
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
1996,
Pubmed
Lim,
Ten years of dengue drug discovery: progress and prospects.
2013,
Pubmed
Liu,
AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus.
2016,
Pubmed
Liu,
Zika Virus Envelope Protein induces G2/M Cell Cycle Arrest and Apoptosis via an Intrinsic Cell Death Signaling Pathway in Neuroendocrine PC12 Cells.
2018,
Pubmed
Menzel,
MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.
2012,
Pubmed
Mittal,
Zika Virus: An Emerging Global Health Threat.
2017,
Pubmed
Mukhopadhyay,
A structural perspective of the flavivirus life cycle.
2005,
Pubmed
Pearson,
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
2001,
Pubmed
Pereira,
SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviral.
2012,
Pubmed
Rice,
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.
1985,
Pubmed
Roby,
Post-translational regulation and modifications of flavivirus structural proteins.
2015,
Pubmed
Sabino,
The Epidermal Growth Factor Receptor Is a Relevant Host Factor in the Early Stages of The Zika Virus Life Cycle In Vitro.
2021,
Pubmed
Scherbik,
Virus-induced Ca2+ influx extends survival of west nile virus-infected cells.
2010,
Pubmed
Schräder,
The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
2018,
Pubmed
Sreekanth,
Role of ERK1/2 signaling in dengue virus-induced liver injury.
2014,
Pubmed
Staples,
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
2015,
Pubmed
Tiwari,
Zika virus infection reprograms global transcription of host cells to allow sustained infection.
2017,
Pubmed
Valencia,
Evaluation of kinase inhibitors as potential therapeutics for flavivirus infections.
2021,
Pubmed
Yang,
Japanese encephalitis virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK/p38 MAPK activation in human promonocyte cells.
2010,
Pubmed
de Oliveira,
The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model.
2020,
Pubmed
